rs81204

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000218.3(KCNQ1):​c.1732+43T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.23 in 1,598,214 control chromosomes in the GnomAD database, including 43,008 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3606 hom., cov: 33)
Exomes 𝑓: 0.23 ( 39402 hom. )

Consequence

KCNQ1
NM_000218.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -3.37

Publications

14 publications found
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 1
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Jervell and Lange-Nielsen syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • atrial fibrillation, familial, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • short QT syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 11-2777075-T-C is Benign according to our data. Variant chr11-2777075-T-C is described in ClinVar as Benign. ClinVar VariationId is 1291253.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.247 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ1NM_000218.3 linkc.1732+43T>C intron_variant Intron 14 of 15 ENST00000155840.12 NP_000209.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ1ENST00000155840.12 linkc.1732+43T>C intron_variant Intron 14 of 15 1 NM_000218.3 ENSP00000155840.2

Frequencies

GnomAD3 genomes
AF:
0.212
AC:
32248
AN:
151962
Hom.:
3596
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.143
Gnomad AMI
AF:
0.252
Gnomad AMR
AF:
0.224
Gnomad ASJ
AF:
0.226
Gnomad EAS
AF:
0.259
Gnomad SAS
AF:
0.223
Gnomad FIN
AF:
0.253
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.239
Gnomad OTH
AF:
0.236
GnomAD2 exomes
AF:
0.226
AC:
55693
AN:
246608
AF XY:
0.228
show subpopulations
Gnomad AFR exome
AF:
0.143
Gnomad AMR exome
AF:
0.190
Gnomad ASJ exome
AF:
0.232
Gnomad EAS exome
AF:
0.267
Gnomad FIN exome
AF:
0.252
Gnomad NFE exome
AF:
0.236
Gnomad OTH exome
AF:
0.237
GnomAD4 exome
AF:
0.232
AC:
335677
AN:
1446134
Hom.:
39402
Cov.:
29
AF XY:
0.232
AC XY:
167115
AN XY:
720132
show subpopulations
African (AFR)
AF:
0.140
AC:
4654
AN:
33138
American (AMR)
AF:
0.197
AC:
8755
AN:
44460
Ashkenazi Jewish (ASJ)
AF:
0.228
AC:
5922
AN:
26016
East Asian (EAS)
AF:
0.224
AC:
8872
AN:
39558
South Asian (SAS)
AF:
0.221
AC:
18927
AN:
85578
European-Finnish (FIN)
AF:
0.254
AC:
13520
AN:
53238
Middle Eastern (MID)
AF:
0.180
AC:
1033
AN:
5746
European-Non Finnish (NFE)
AF:
0.237
AC:
259814
AN:
1098512
Other (OTH)
AF:
0.237
AC:
14180
AN:
59888
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
14345
28690
43034
57379
71724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8800
17600
26400
35200
44000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.212
AC:
32300
AN:
152080
Hom.:
3606
Cov.:
33
AF XY:
0.213
AC XY:
15814
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.144
AC:
5977
AN:
41480
American (AMR)
AF:
0.225
AC:
3435
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.226
AC:
783
AN:
3470
East Asian (EAS)
AF:
0.258
AC:
1332
AN:
5160
South Asian (SAS)
AF:
0.221
AC:
1067
AN:
4818
European-Finnish (FIN)
AF:
0.253
AC:
2675
AN:
10576
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.239
AC:
16232
AN:
67984
Other (OTH)
AF:
0.242
AC:
508
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1304
2608
3911
5215
6519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
352
704
1056
1408
1760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.226
Hom.:
5479
Bravo
AF:
0.205
Asia WGS
AF:
0.292
AC:
1016
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.052
DANN
Benign
0.49
PhyloP100
-3.4
PromoterAI
0.0016
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs81204; hg19: chr11-2798305; COSMIC: COSV50112501; COSMIC: COSV50112501; API